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Calling on Europe to support operational research in 
low-income and middle-income countries
Operational research in public health is the investigation 
of strategies, interventions, instruments, or knowledge 
that can enhance the quality, coverage, eﬀ ectiveness, 
or performance of health systems, health services, or 
disease control programmes.1 By showing what works 
and what does not in various contexts, operational 
research can provide evidence to help policy makers to 
adapt health interventions and services for maximum 
public health beneﬁ t.2
During a recent workshop organised by the Science 
and Technology Options Assessment body (STOA) of the 
European Parliament, experts in the ﬁ eld of operational 
research concluded that the European Union (EU) 
should increase its support for this form of research. 
STOA, which provides independent assessments of 
scientiﬁ c and technological options in various sectors 
including the life sciences, organised the workshop 
in collaboration with Médecins Sans Frontières, the 
International Union Against Tuberculosis and Lung 
Disease, and WHO/TDR.
The participants discussed several overarching themes, 
concluding that research is too often separate from 
implementation. A crucial gap remains between the 
development of eﬃ  cacious health interventions and 
their optimum delivery in real-life settings. This gap 
is particularly true in many low-income and middle-
income countries (LMICs). For example, two-thirds of 
childhood deaths are potentially avoidable with known 
technologies that are implemented to scale.3 Similarly, 
results of clinical trials have shown major beneﬁ ts of 
parenteral artesunate compared with quinine to treat 
malaria, but quinine remains the standard treatment 
in most malaria-endemic countries.4 Operational 
research could show how to introduce and scale up such 
interventions, which could have a major eﬀ ect on global 
health.5
Many LMICs are rich in data, but have insuﬃ  cient 
information. Massive amounts of routine data are 
collected within public health systems such as by 
ministries of health (MOH) and non-governmental 
organisations (NGOs), but are underused, reducing 
the potential eﬀ ect of research on policy and practice. 
Compounding the problem, most data collected at 
national level are of little use at the point of care; 
research instruments to assess equity need to be easily 
manageable at district level to prompt eﬀ ective actions.6 
The World Health Report 2013 by WHO7 recommended 
that all countries should become producers as well 
as consumers of research, and that research capacity 
should extend beyond academic centres to public health 
programmes—close to the supply and demand for 
health services.
In this context, the Structured Operational 
Research and Training Initiative (SORT IT), a global 
partnership led by the WHO/TDR, could serve as a 
global springboard for country-level capacity building. 
SORT IT programmes support countries to undertake 
operational research in accordance with their own 
priorities, develop adequate and sustainable operational 
research capacity in public health programmes, and 
create an organisational culture of policy and practice 
being informed by operational research, leading to 
improved programme performance.8
The initiative teaches the practical skills needed to 
undertake and publish operational research.9 SORT IT 
holds training programmes of 10–12 months with clear 
targets. By January, 2014, 18 programmes had been 
run, enrolling 212 participants from 60 countries, 
mainly in Africa and Asia. Of the ﬁ rst eight completed 
courses, 89% of 93 enrolled participants successfully 
completed these courses and 93% of 96 submitted 
papers were published within 18 months of 
completion. Of published papers, 74% were reported to 
have had an eﬀ ect on policy and practice. Moreover, the 
average cost per publication was only €6800. Although 
the comparison is not completely appropriate because 
of the potential greater value of long-term basic 
scientiﬁ c research, the average cost of EU-funded 
research is €140 000–220 000 per publication.10
Researchers and experts recognised that very 
little funding is available for operational research 
within health programmes and they discussed 
some possible solutions. Embedding research into 
national programmes and health systems would be 
one way of ensuring cost-eﬃ  ciency. In this way, the 
traditional call for funding applications would need 
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to be complemented with integrated funding made 
available within the programme structure, which 
would encourage MOHs and NGOs in LMICs to embrace 
operational research more fully.11 Through NGOs, 
settings often excluded from research activities, such 
as those in conﬂict and disaster, could also beneﬁ t.12 
Although international institutions such as the Global 
Fund to Fight AIDS, Tuberculosis and Malaria allow a 
sizeable proportion of country grants to be invested in 
operational research, absorption of such funds has been 
poor because of the absence of operational research 
capacity in-country. The SORT IT model is one way to 
maximise the use of such funding opportunities.
Arising from these issues, identiﬁ ed by the European 
Parliament event, was the contribution that the EU 
could make to operational research. As the world’s 
largest aid donor, the EU is well positioned to support 
international research collaboration, which works as a 
type of science diplomacy. Until now, EU investment 
in research has been directed towards innovation, 
an essential part of the EU Framework Programmes 
mission. However, knowledge of how to implement new 
ﬁ ndings for maximum public health beneﬁ t is too often 
insuﬃ  cient and should be enhanced by complementary 
EU actions for social innovations that enable operational 
research. The European and Developing Countries 
Clinical Trials Partnership (EDCTP), which is part of the 
EU Framework Programmes, plays an important part 
in supporting clinical research and capacity building in 
African countries. However, although the new extended 
remit of EDCTP includes elements of implementation 
research, the main focus is on product development, 
and a necessary continuum would be to support 
operational research so that the results of EDCTP trials 
can be eﬀ ectively applied.
In LMICs, the EU could eﬀ ectively boost operational 
research, which could in turn connect organisations 
that have technical skills in operational research with 
national public health programmes and strengthen 
capacity building through north-to-south and south-
to-south partnerships. Operational research fellows 
could be key to building a critical mass of researchers in 
the public sector who could then be retained. As part of 
this, the European Commission should establish a clear 
strategy for operational research, develop a common 
policy, and increase coordination between diﬀ erent 
Directorates-General (Research, Development).
The EU is one of the world’s most proliﬁ c funders 
of both research and development cooperation, but 
only very few actions relate speciﬁ cally to operational 
research in LMICs. There is ample opportunity to use the 
available ﬁ nancial and political power to better meet 
these ends.
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